This cross-sectional study reveals supraspinatus tendon thickness differences in type 2 diabetes, suggesting potential diagnostic implications.
Objective: The aim of this study was to compare the thickness of the supraspinatus tendon (SST) in participants with type 2 diabetes mellitus (DM) with normal healthy individuals. Materials and Methods: There were 80 participants enrolled in the study, with type 2 DM and 80 participants served as a control group. The supraspinatus tendon thickness (SSTT) was assessed using gray-scale ultrasonography. Results: The mean SSTT was significantly higher in the DM group than the control group, on the dominant and non-dominant shoulders (6.82 ± 1.23 vs 4.78 ± 0.64 mm; t test = 13.64, p < .001 and 6.86 ± 1.33 vs 4.69 ± 0.49 mm; t test = 14.10, p < .001). Dominant and non-dominant shoulder SSTT in the DM participants significantly correlated with age ( r = −0.229 and r = −0.301, p < .05) and glycated hemoglobin (HbA1c; r = 0.753 and r = 0.468, p < .05). HbA1c significantly correlated with SSTT on both shoulders in the control group ( r = 0.256 and r = 0.297, p < .05). Conclusion: In this cohort, the SSTT was significantly greater for those with DM than those non-diabetic individuals, and in the DM group, it was significantly associated with young age and increase in HbA1c. Sonographic evaluation of SSTT may be a useful diagnostic tool to determine tendinopathy in DM patients, in the absence of shoulder pain.
No takes yet. Share an insight, caveat, or question.
Douglas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: